New CEO announced!

Discussion in 'GlaxoSmithKline' started by anonymous, Sep 20, 2016 at 6:07 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    It's Emma!!!!
     

  2. anonymous

    anonymous Guest

    You seem surprised.
     
  3. anonymous

    anonymous Guest

    Her 17 yrs at L'Oraleale will come in handy for cover-ups of every kind.

    [​IMG]
     
  4. anonymous

    anonymous Guest

    what a pathetic choice, final nail in the coffin for GSK
     
  5. anonymous

    anonymous Guest

    Thanks for your EXPERT opinion.
     
  6. anonymous

    anonymous Guest

    I hope everyone understands that all of GSKs lawsuits and pipeline problems happened before Emma became CEO. Those former GW people (Witty) were unethical, so any under performance is due to the merger and legacy company.
     
  7. anonymous

    anonymous Guest

    Looks like major shareholders have reacted- 42 and dropping.............................
     
  8. anonymous

    anonymous Guest

    To post #7. $43 and climbing today. HAH HAHAHAHAHAHA!! NO LAYOFFS!!! COME BACK IN 2018! HA AHAHAHAHAHAHAHAHAHA
     
  9. anonymous

    anonymous Guest

    Agreed, $43+ today. Give Dame Emma a chance. We got stuck with Sir Andrew for a decade, we can at least give Dame Emma a few days before the Monday morning quarterbacks start piling on. I bet she will be fantastic.
     
  10. anonymous

    anonymous Guest

    It's all about the epipen strategy!
    [​IMG]
     
  11. anonymous

    anonymous Guest

    Nothing wrong with her individually, just question the strategy of hiring a non medical/science person with zero pharma pipeline or formulary experience in to a patent cliff situation. More toof paste sales won't save us.